Renin–angiotensin system blockade in the COVID-19 pandemic

In the early months of the coronavirus disease 2019 (COVID-19) pandemic, a hypothesis emerged suggesting that pharmacologic inhibitors of the renin–angiotensin system (RAS) may increase COVID-19 severity. This hypothesis was based on the role of angiotensin-converting enzyme 2 (ACE2), a counterregul...

Descripción completa

Detalles Bibliográficos
Autores principales: Cohen, Jordana B, South, Andrew M, Shaltout, Hossam A, Sinclair, Matthew R, Sparks, Matthew A
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2021
Materias:
CKJ Reviews
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7929063/
https://www.ncbi.nlm.nih.gov/pubmed/33796285
http://dx.doi.org/10.1093/ckj/sfab026

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7929063/
https://www.ncbi.nlm.nih.gov/pubmed/33796285
http://dx.doi.org/10.1093/ckj/sfab026

Ejemplares similares